Best Stocks To Buy For 2022 According To Analysts

0

According to Goldman Sachs, the S&P 500 is predicted to gain 9% through 2022. The index is expected to end the year at 5,100, representing a total return of 10% when dividends are factored in. Analysts are optimistic about the market’s development prospects in 2019. The Bank of America’s Kostin Capital expects the US economy to develop steadily in the next months. The bank notes the S&P 500’s unchanged corporate tax rates, 8% profits growth, and 9% year-over-year sales growth.

Here is Insider Monkey’s list of the 15 best stocks to buy for 2022 according to analysts. The US economy will rise steadily in the next months, according to Kostin Capital at Bank of America. In the S&P 500, the bank points to unchanged corporate tax rates, 8% profits growth, and 9% year-over-year sales growth. Harmony Biosciences Holdings, Inc. is a pharmaceutical business focused on developing treatments for individuals suffering from uncommon neurological illnesses. According to Goldman Sachs, the company is on track for a 52 percent sales growth rate over the next three years and a 37 percent profit margin in 2023. Lattice Semiconductor Corporation is a semiconductor manufacturer and distributor. Benchmark, KeyBanc, and Craig-Hallum have lifted the stock’s price targets. Advanced artificial intelligence and computer vision apps are also being developed by the software company. Rare earth mining and processing company MP Materials Corp. A recent story in The Wall Street Journal said that China was in the midst of forming a new state-owned rare earths corporation in order to preserve global dominance. Asset optimization solutions are provided by Aspen Technology, Inc. The company has been praised by Bank of America analyst Andrew Obin for sales growth and profitability expansion. Insider Monkey’s database revealed that 20 hedge funds had $620 million invested in Aspen Technology. In October, Avid Bioservices, Inc. stated that it would expand its manufacturing and contract development services to the cell and gene therapy sector. According to Goldman Sachs, the company’s sales will expand at a rate of 32 percent over the following three years. For more details, click the 15 Best Stocks To Buy For 2022 According To Analysts.

 

Share.